Efficacies of anlotinib monotherapy versus gemcitabine-based chemotherapy for patients with advanced soft tissue sarcoma after the failure of anthracycline-based chemotherapy
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-023-05575-4
Abstract: Objective The purpose of this study was to compare the antitumor efficacy of anlotinib with gemcitabine-based chemotherapy as subsequent treatment regimens in patients with advanced non-specific soft tissue sarcoma (STS) after the failure of anthracycline-based… read more here.
Keywords: anthracycline based; gemcitabine based; anlotinib gemcitabine; chemotherapy ... See more keywords
The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415
Sign Up to like & getrecommendations! Published in 2024 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-024-08717-7
Abstract: To examine the differential effect of non- and anthracycline-based chemotherapy on fatigue over 12 months post-diagnosis among breast cancer survivors. This study is based on a prospective Wake Forest NCI Community Oncology Research Program (NCORP)… read more here.
Keywords: cancer; breast cancer; anthracycline based; chemotherapy ... See more keywords
The Double-Edged Sword: Controversies in Anthracycline-Based Chemotherapy for Breast Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Current Breast Cancer Reports"
DOI: 10.1007/s12609-017-0254-7
Abstract: Purpose of ReviewThis review article seeks to summarize the existent literature regarding the use of anthracyclines (specifically doxorubicin) in the treatment of early-stage breast cancers, reviewing the clinically significant side effects of said therapy, and… read more here.
Keywords: risk; breast; breast cancer; based chemotherapy ... See more keywords
Evaluation of dexrazoxane effect on preventing acute cardiac arrhythmia in patients with breast cancer treated with neoadjuvant/adjuvant anthracycline‐based chemotherapy
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.14705
Abstract: Adding dexrazoxane to the treatment during neoadjuvant/adjuvant anthracycline‐based chemotherapy in patients with breast cancer prevents the development of heart failure. In this study, we investigated whether dexrazoxane has a protective effect on arrhythmia resulting from… read more here.
Keywords: patients breast; neoadjuvant adjuvant; adjuvant anthracycline; based chemotherapy ... See more keywords
A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
Sign Up to like & getrecommendations! Published in 2025 at "BMC Cancer"
DOI: 10.1186/s12885-024-13305-3
Abstract: Anthracycline usage has been linked to cardiovascular adverse events (CAEs), which is unpredictable. It is critical to identify the characteristics of vulnerable populations and risk factors in order to reduce the occurrence of CAEs. This… read more here.
Keywords: anthracycline based; meta analysis; risk; caes ... See more keywords
Standard anthracycline-based vs. docetaxel-capecitabine in early breast cancer: Results from the chemotherapy randomization (R-C) of EORTC 10041/ BIG 3-04 MINDACT phase III trial.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.516
Abstract: 516Background: The MINDACT trial demonstrated that 46% of breast cancer patients (pts) at high clinical (C) but low genomic (G) risk based on MammaPrint (70-gene signature), might safely forego adjuvant CT (Cardoso NEJM 2016). A… read more here.
Keywords: anthracycline based; trial; standard anthracycline; breast cancer ... See more keywords
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13194877
Abstract: Simple Summary High-risk soft tissue sarcomas (HR-STS) account for less than 1% of all malignancies in adults. Despite optimal local treatment, almost half of patients will die within five years of their diagnosis. Chemoresistance is… read more here.
Keywords: chemotherapy; neoadjuvant anthracycline; top2a sirt1; expression ... See more keywords
Cardiac magnetic resonance assessment of the effect of anthracycline-based chemotherapy on cardiac structure and function in breast cancer patients
Sign Up to like & getrecommendations! Published in 2024 at "Tropical Journal of Pharmaceutical Research"
DOI: 10.4314/tjpr.v23i10.16
Abstract: Purpose: To use cardiac magnetic resonance (CMR) imaging to investigate the effect of anthracycline-based chemotherapy on cardiac structure and function in breast cancer patients. Methods: A total of 20 breast cancer patients who received treatment… read more here.
Keywords: cancer; breast cancer; anthracycline based; cancer patients ... See more keywords